The estimated incidence of scalp psoriasis among psoriatic patients is 45–56% of (2). In one epidemiological study it was found that up to 90% of psoriatic patients may have the scalp affected by the disease at some point during their lifetimes (3, 4)

Scalp psoriasis manifests as patches and silvery white scales that flake. The involved skin is exceedingly dry, often causing cracking and bleeding on its surface. Many patients also complain about sensations of pain or burning (5).

Scalp psoriasis has a significant negative impact on their quality of life. More than 70% of these patients report difficulty with everyday activities. Patients often experience the feeling of shame, embarrassment or self-consciousness about their scalp lesions and as a consequence wear hats or grow their hair long to hide the defect.

A large group of psoriatic patients with severe scalp involvement present mild involvement of the body skin and in consequence they may not meet the criteria to receive systemic therapy for moderate-to-severe psoriasis vulgaris. Thus, the most frequent therapy is based on topical agents, usually with only temporary effect and frequent recurrence.

Patients with scalp psoriasis need care. Daxxin is tested and has proven efficacy for irritation and itching, redness, flaking, as well as scratches and sores on the scalp. The shampoo can relieve symptoms of psoriasis on the scalp and has no known side effects.